HR Execs on the Move

Saniona

www.saniona.com

 
Saniona is a rare disease biopharmaceutical company focused on research, development and commercialization of treatments for the central nervous system. The company has four programs in clinical
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.saniona.com
  • 500 Totten Pond Road Suite 620
    Waltham, MA USA 02451
  • Phone: 781.839.9100

Executives

Name Title Contact Details
Linea Aspesi
Chief Human Resources Officer Profile
Linea Aspesi
Chief Human Resources Officer Profile

Similar Companies

RW Troxell

RW Troxell is a Springfield, IL-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

HumanCo

HumanCo is a mission-driven private holding company that invests in and builds brands focused on healthier living and sustainability.

The Medicines Company

The Medicines Company`s purpose is to save lives, alleviate suffering and contribute to the economics of healthcare by focusing on 3,000 leading acute/intensive care hospitals worldwide. Its vision is to be a leading provider of solutions in three areas: acute cardiovascular care, surgery and perioperative care, and serious infectious disease care. The company operates in the Americas, Europe and the Middle East, and Asia Pacific regions with global centers today in Parsippany, NJ, USA and Zurich, Switzerland.

Theseus Pharmaceuticals

Theseus is a biopharmaceutical company focused on improving the lives of cancer patients through the discovery, development and commercialization of transformative targeted therapies. Theseus is developing next-generation tyrosine kinase inhibitors (TKIs): "pan-variant" targeted therapies that address all major drug resistance mutations. Theseus` lead product candidate, THE-630, is a pan-variant KIT inhibitor for the treatment of patients with advanced gastrointestinal stromal tumors (GIST), whose cancer has developed resistance to earlier lines of kinase inhibitor therapy. Theseus is also developing a fourth-generation, selective epidermal growth factor receptor (EGFR) inhibitor for C797S-mediated resistance to first- or later-line osimertinib treatment in patients with non-small cell lung cancer (NSCLC).

TearScience

TearScience is a Morrisville, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.